Innovative mental health medicines
Our Target
Stock & Sector Performance
ABRT vs. Peers
Stoic Report (Oct 22)
Psychedelics Index June
October 2022
Key Assets
Value created from $4.7 million Series A raise
Canada
Portugal
UK
Australia
Accomplished Management Team
Previous experience...
Next Steps:
Value Milestones
Clinical development programme with comparable valuations
Invest in a breakthrough technology for mental health
Reserve your shares…
Contact us directly for discounted shares
CANADIAN SECURITIES EXCHANGE RULES HAVE CHANGED
Click here to access our investor documents